Medication-Assisted Treatment - Prescription Drug and Opioid Addiction

The Substance Abuse and Mental Health Services Administration, under the Department of Health and Human Services, is seeking proposals under solicitation TI-26-008 to expand and enhance access to Medications for Opioid Use Disorder, aiming to increase treatment and recovery opportunities for individuals with Opioid Use Disorder while reducing illicit opioid use, prescription opioid misuse, and overdose incidents. This federal solicitation targets organizations capable of implementing programs that improve the availability and quality of medication-assisted treatment services across the United States, with no geographic restrictions specified for performance. The solicitation was posted on July 1, 2026, and responses are due by July 27, 2026, with no set-aside provisions applied. Interested applicants must direct inquiries to Rachel Bailey, the Content Administrator, via email at nofobudget.csat@samhsa.hhs.gov or phone at 301-367-3764. All proposals must align with the program’s objective of strengthening the nation’s response to the opioid crisis through accessible, evidence-based treatment interventions.